Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dermatitis, Atopic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00139581
What this trial is testing

Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects

Who this might be right for
Atopic Dermatitis
Novartis
Not applicableUnknownNCT05078294
What this trial is testing

Results in Real Clinical Practice of Treatment of Moderate-severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 300
Early research (Phase 1)Study completedNCT04668066
What this trial is testing

Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer 121
Large-scale testing (Phase 3)Study completedNCT03745651
What this trial is testing

TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Incyte Corporation 618
Post-approval studies (Phase 4)WithdrawnNCT03710044
What this trial is testing

Investigation of Flare and Remission in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
LEO Pharma
Not applicableStudy completedNCT00929981
What this trial is testing

Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients

Who this might be right for
Dermatitis, Contact
Pfizer 80
Testing effectiveness (Phase 2)Study completedNCT07712536
What this trial is testing

Phase IIa Study of Pharmacokinetics, Safety and Efficacy of QY201 Tablets in Adolescent Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Adolescent Participants With Moderate to Severe Atopic Dermatitis (AD)
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. 24
Not applicableEnrolling By InvitationNCT03976622
What this trial is testing

Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata

Who this might be right for
VitiligoPsoriasisAlopecia Areata+1 more
University Hospital, Bordeaux 450
Not applicableUnknownNCT05636839
What this trial is testing

UVB-induced Treg Cells Exert Antigen-specific Suppression Through LAG-3

Who this might be right for
PsoriasisAtopic Dermatitis
National Taiwan University Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT07011706
What this trial is testing

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisAtopicDermatitis+2 more
Aclaris Therapeutics, Inc. 110
Not applicableStudy completedNCT01591785
What this trial is testing

Treatment of Staphylococcus Aureus Colonization in Hand Eczema

Who this might be right for
Hand EczemaFoot Eczema
Gary Goldenberg 60
Not applicableActive Not RecruitingNCT05387980
What this trial is testing

Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Pfizer 1,128
Large-scale testing (Phase 3)Not Yet RecruitingNCT06884891
What this trial is testing

A Phase Ⅲ Comparative Study of QL2108 to Dupixent®

Who this might be right for
Atopic Dermatitis
Qilu Pharmaceutical Co., Ltd. 520
Large-scale testing (Phase 3)Study completedNCT03349060
What this trial is testing

Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 387
Early research (Phase 1)Study completedNCT01428297
What this trial is testing

A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome

Who this might be right for
Healthy VolunteersAtopic DermatitisNetherton Syndrome
Novartis Pharmaceuticals 12
Early research (Phase 1)Study completedNCT04927195
What this trial is testing

Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma

Who this might be right for
Atopic DermatitisPsoriasisAsthma
Evelo Biosciences, Inc. 52
Not applicableStudy completedNCT02889081
What this trial is testing

Maternal Key Nutritional Factors and Offspring's Atopic Dermatitis (MKNFOAD)

Who this might be right for
Atopic Dermatitis
Children's Hospital of Fudan University 487
Not applicableEnded earlyNCT00931411
What this trial is testing

Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Cosmetique Active International 73
Testing effectiveness (Phase 2)Ended earlyNCT03809663
What this trial is testing

A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amgen 251
Large-scale testing (Phase 3)Not Yet RecruitingNCT07784816
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetic Profiles of TLL-018 in Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Hangzhou Highlightll Pharmaceutical Co., Ltd 390
Next Page